Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Life Span Health
- Infectious/ Immunological Health
- Specialized Health
- Metabolic Health
Fingerprint
Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
-
Evaluate the efficacy of a T cell-based human vaccine against CoV-2 Infection
Tseng, C.-T. (PI)
Massachusetts Institute of Technology
4/29/22 → 12/31/22
Project: Research project
-
Clinical Study Protocol for COVID-19 Antigen Test - Omicron Variant
Tseng, C.-T. (PI)
1/24/22 → 1/23/23
Project: Research project
-
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection
Song, I. W., Washington, M., Leynes, C., Hsu, J., Rayavara, K., Bae, Y., Haelterman, N., Chen, Y., Jiang, M. M., Drelich, A., Tat, V., Lanza, D. G., Lorenzo, I., Heaney, J. D., Tseng, C. T. K., Lee, B. & Marom, R., Jun 2024, In: Mammalian Genome. 35, 2, p. 113-121 9 p.Research output: Contribution to journal › Article › peer-review
-
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Carter, B., Huang, P., Liu, G., Liang, Y., Lin, P. J. C., Peng, B. H., McKay, L. G. A., Dimitrakakis, A., Hsu, J., Tat, V., Saenkham-Huntsinger, P., Chen, J., Kaseke, C., Gaiha, G. D., Xu, Q., Griffiths, A., Tam, Y. K., Tseng, C. T. K. & Gifford, D. K., 2023, In: Frontiers in immunology. 14, 1135815.Research output: Contribution to journal › Article › peer-review
Open Access -
Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases
Calvier, L., Drelich, A., Hsu, J., Tseng, C. T., Mina, Y., Nath, A., Kounnas, M. Z. & Herz, J., 2023, In: Frontiers in immunology. 14, 1185748.Research output: Contribution to journal › Article › peer-review
Open Access -
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Ma, H., Guo, Y., Tang, H., Tseng, C. T. K., Wang, L., Zong, H., Wang, Z., He, Y., Chang, Y., Wang, S., Huang, H., Ke, Y., Yuan, Y., Wu, M., Zhang, Y., Drelich, A., Kempaiah, K. R., Peng, B. H., Wang, A. & Yang, K. & 30 others, , Dec 2022, In: Cell Discovery. 8, 1, 16.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines (PLoS ONE (2013) 8:12 (e81587) DOI: 10.1371/journal.pone.0081587)
Du, L., Kou, Z., Ma, C., Tao, X., Wang, L., Zhao, G., Chen, Y., Yu, F., Tseng, C. T. K., Zhou, Y. & Jiang, S., Dec 2022, In: PloS one. 17, 12 December, e0278474.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Press/Media
-
WHO statement on COVID-19 vaccine
Kobinger, G., Brasel, T. & Tseng, C.-T.
4/14/20
1 item of Media coverage
Press/Media: Expert Comment
-
Public statement for collaboration on COVID-19 vaccine development
Kobinger, G., Brasel, T. & Tseng, C.-T.
4/13/20
1 item of Media coverage
Press/Media: Expert Comment